13F-HR filed by Lion Point Capital, LP
Lion Point Capital, LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 25 holding rows worth $44,906,962.
- Accession
- 0001013594-24-000964
- Filer
- CIK 1643354
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 25 entries on the cover page, a total value of $44,906,962 stated on the cover page (in dollars after the unit check, H1), rows summing to $44,906,962 with VALUE read as dollars as filed, 13F file number 028-17316. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| iShares Russell 2000 ETF | 464287655 | SHS | 82,500 | $18,223,425 | dollars as filed | put |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 52,200 | $3,810,600 | dollars as filed | |
| GERON CORP | 374163103 | COM | 630,000 | $2,860,200 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 370,000 | $2,549,300 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 1,654,154 | $2,514,314 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 35,400 | $1,768,938 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 45,000 | $1,755,000 | dollars as filed | put |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 61,400 | $1,534,386 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 49,000 | $1,247,540 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 693,778 | $1,221,049 | dollars as filed | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 215,000 | $1,075,000 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 79,000 | $956,690 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 46,200 | $889,350 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 64,000 | $839,360 | dollars as filed | |
| BLUEBIRD BIO INC | 09609G100 | COM | 1,578,256 | $819,904 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 57,750 | $605,798 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 32,000 | $601,920 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 7,700 | $378,378 | dollars as filed | |
| BENITEC BIOPHARMA INC | 08205P209 | COMMON STOCK | 39,000 | $358,410 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 35,100 | $326,430 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 340,761 | $322,394 | dollars as filed | |
| LUMOS PHARMA INC | 55028X109 | COM | 39,589 | $153,209 | dollars as filed | |
| Microsoft Corp | 594918104 | COM | 100 | $43,030 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 75,000 | $35,618 | dollars as filed | |
| Alphabet Inc. Reg. Shares C | 02079K107 | COM | 100 | $16,719 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001013594-24-000964 | this filing | 2024-11-14 | acceptance time not in the bulk data set |